Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
about
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesEmulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responsesInduction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.Glycated chitosan as a new non-toxic immunological stimulant.Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.Preparation of alginate coated chitosan microparticles for vaccine deliveryChitosomes loaded with cranberry proanthocyanidins attenuate the bacterial lipopolysaccharide-induced expression of iNOS and COX-2 in raw 264.7 macrophages.Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesA new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasisEvaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems.A polymer/oil based nanovaccine as a single-dose immunization approach.Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.Exploiting fungal cell wall components in vaccinesInCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityAn adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMVImmunostimulative Activity of Low Molecular Weight Chitosans in RAW264.7 Macrophages.N-dihydrogalactochitosan as a potent immune activator for dendritic cells.Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin.Exercise enhances vaccine-induced antigen-specific T cell responses.The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cellsChitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineEnergy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice.Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activityChitosan solution enhances the immunoadjuvant properties of GM-CSF.Improving vaccines by incorporating immunological coadjuvants.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Molecular Weight-Dependent Immunostimulative Activity of Low Molecular Weight Chitosan via Regulating NF-κB and AP-1 Signaling Pathways in RAW264.7 Macrophages.Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.Chitosan-based systems for the delivery of vaccine antigens.Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection.Controlling chitosan-based encapsulation for protein and vaccine delivery.Progress towards a needle-free hepatitis B vaccine.Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy.
P2860
Q26766552-0B81DDB1-AB4F-4968-AA5F-AB7397573822Q26852816-9532E21F-0D96-4D1A-830C-6F0422B3BC0BQ27332152-C9B67EAF-9A1F-4016-9B93-739D12CEF9E3Q30382453-2F8A3760-36C0-4AC8-B6C0-ED3456EDD341Q30397973-5F480BC3-6622-43CD-989B-2A9071D75BB4Q30865136-F1C6FF53-DAFB-42BB-A781-FD50E55E12E2Q31076192-5F114C96-A0D2-4D7A-9DE6-2C0955F0E12AQ33385532-3E86DD6B-E936-4D61-B430-9B72487EF742Q33495322-26BC945D-3DEB-466A-96D9-F9D14757C8D2Q33612179-DC69B2AE-7BB2-4F06-88E6-4AB1C047CD8FQ34033764-DA7DCC9B-24D6-4355-9724-FA4DD1CA2DCBQ34356322-B956A673-1A2D-4B64-8702-0647F5AFA555Q34500826-DC7FED63-0E15-4241-8973-AF7172A08F8BQ34524955-6EEE941B-5584-4C41-95F2-76583C7A452CQ34544509-5C7ACC72-AEEC-4E3A-9F55-08364266E522Q34685874-613A0EDF-D359-4788-A78E-9F821EA6A391Q34956373-B418BB66-55BF-4F8D-9B54-DD2DB1788E43Q35085200-E26B1C05-3A58-456D-BED5-21726E1E6C7DQ35108944-D2C7396C-FFE7-433A-AA06-3C0CB9FEEF7EQ35144633-1CC88292-EBAB-4B9E-9E1B-B62DA9F93444Q36226743-CFE8B4F2-842C-4D13-8FDA-15A8CBC16CB0Q36234323-AE30D589-FF5C-4EF6-834A-3EF4B44C2B79Q36310762-04B79BB8-3B81-410A-A36F-47B8D254DA3DQ36391000-69562E60-5945-4A6C-B714-44787E499249Q36422431-2048FCDE-0BB1-4A73-A762-5CFA1FA32F46Q36553255-A55916B2-E492-4D90-85FB-3E33B2BAB2B8Q36582241-01DE8D97-19A5-4C44-BD88-D3D7B275F4C9Q36702887-BE502DB5-C51F-4A05-B6C7-FEE4D6070AE2Q36727500-1F9A8F55-284E-4497-8C79-9801D6C70F5CQ36731317-D9091003-7B44-4218-937B-1DA6874606AAQ36868870-BB15DC78-3524-4CE3-91C9-97BB4DB851F6Q36899084-8EDC51E8-496B-4CA1-862D-C86F66305266Q36978334-173989F4-5144-4FC1-8ED3-593F589D4816Q37290929-CCF88924-9B97-4E3E-B81A-02D287C0F436Q37473416-CC39E4CB-324F-414B-8DC3-668E1768051FQ37524050-899B3168-3960-47F8-9CCD-F7B3D46DE108Q37554162-C592F1B4-FB0E-40A8-963C-E22FAE08888FQ37684382-BC210E9D-02BB-4757-B8D8-DB30D84A4670Q37810816-761700BB-27CC-4803-B6FD-00EEF4AD9531Q37883474-833D5BBD-7971-4BBB-ACC9-A9F29715B8FD
P2860
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@ast
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@en
type
label
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@ast
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@en
prefLabel
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@ast
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@en
P2093
P2860
P1433
P1476
Chitosan solution enhances bot ...... s to subcutaneous vaccination.
@en
P2093
Connie J Rogers
Jeffrey Schlom
John W Greiner
Kenneth W Hance
P2860
P304
P356
10.1016/J.VACCINE.2006.11.034
P407
P577
2006-12-04T00:00:00Z